Research studies

Breast Cancer Care undertakes research to support the overall vision and mission of the organisation, which is to provide the highest standards of treatment, support and care through the provision of high quality, innovative and responsive services.

BABS Project
In July 2006, Breast Cancer Care in collaboration with Kings College London, was successful in achieving a Knowledge Transfer Partnership (KTP) award from the Department of Trade and Industry.

Living with secondary breast cancer
Little is known about the practical and emotional effects of living with secondary breast cancer or about the support needs of those people with it.

Diversity research
Breast Cancer Care is committed to ensuring that everyone in the UK has equal access to high quality accurate information about breast awareness and breast cancer.

80 over 50: 80 over 50 Breast Awareness Survey (2003)
Eighty percent of breast cancer cases in the UK are diagnosed in women over the age of 50 years.

Evaluating our services
Breast Cancer Care is committed to providing high quality services that meet the needs of people with breast cancer.

Press Releases

Breast Cancer Care responds to MPs' rejection of House of Loards amendments to the Welfare Reform Bill

Responding to MPs’ rejection of the House of Lords’ amendments to the Welfare Reform Bill in the House of Commons today (Wednesday 1 February 2012), Liz Carroll, Director of Policy and Research at Breast Cancer Care said:

Breast Cancer Care: Valuing Older Women

Breast Cancer Care is publishing recommendations on how to improve outcomes and experiences for older women with breast cancer in a new policy briefing, supported by Age UK.

Breast Cancer Care launches policy briefing: Improving outcomes and experiences for older women with breast cancer

Breast Cancer Care, the leading breast cancer support and information charity in the UK, has produced a new report, backed by Age UK, that makes clear recommendations to improve outcomes and experiences for older women with breast cancer, a demographic proven to have poorer relative survival rates and an increased likelihood of presenting later with symptoms and of receiving non-standard treatments.

Breast Cancer Care: Reaction to NICE recommendation on bevacizumab (Avastin)

Commenting on NICE's recommendation on bevacizumab (Avastin), Dr Emma Pennery, Clinical Director at Breast Cancer Care said.

Breast Cancer Care on research published in the Lancet Oncology online

The results of this large-scale study are very reassuring as they confirm that current NICE guidance1 , which recommends annual mammograms for women over 40 who are at an increased risk of breast cancer, is effective.

More Articles ...

Newsletter sign up

By signing-up you agree to the terms of use and privacy policy.

Unsubscribe